{"product_id":"biolegend-104707","title":"Biolegend, 104707, PE anti-mouse CD80 Antibody, 50μg","description":"\u003cp\u003eCD80 is a 60 kD highly glycosylated protein. It is a member of the Ig superfamily and is also known as B7-1, B7, and Ly-53. CD80 is constitutively expressed on dendritic cells and monocytes\/macrophages, and inducibly expressed on activated B and T cells. The ligation of CD28 on T cells with CD80 and CD86 (B7-2) on antigen presenting cells (such as dendritic cells, macrophages, and B cells) elicits co-stimulation of T cells resulting in enhanced cell activation, proliferation, and cytokine production. CD80 appears to be expressed later in the immune response than CD86. CD80 can also bind to CD152, also known as CTLA-4, to deliver an inhibitory signal to T cells.\u003cbr\u003e\n50μg\u003cbr\u003e\nVerified Reactivity: Mouse\u003cbr\u003e\nReported Reactivity: Dog\u003cbr\u003e\nAntibody Type: Monoclonal\u003cbr\u003e\nHost Species: Armenian Hamster\u003cbr\u003e\nImmunogen: CHO cell line transfected with mouse B7 (CD80)\u003cbr\u003e\nFormulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.\u003cbr\u003e\nPreparation: The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.\u003cbr\u003e\nConcentration: 0.2 mg\/ml\u003cbr\u003e\nStorage \u0026amp; Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.\u003cbr\u003e\nApplication: FC - Quality tested\u003cbr\u003e\nRecommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.\u003cbr\u003e\nExcitation Laser: Blue Laser (488 nm)Green Laser (532 nm)\/Yellow-Green Laser (561 nm)\u003cbr\u003e\nApplication Notes: Additional reported applications (for the relevant formats) include: immunoprecipitation2, in vitro and in vivo blocking of CTLA-4 Ig to CD80 by blocking costimulation of T cells by activated B cells2-4, and immunohistochemical staining of acetone-fixed frozen sections1,4. The Ultra-LEAF™ purified antibody (Endotoxin \u0026lt; 0.01 EU\/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. Nos. 104747-104752).\u003cbr\u003e\nApplication References(PubMed link indicates BioLegend citation): Harlan DM, et al. 1994. P. Natl. Acad. Sci. USA 91:3137. (IHC) Razi-Wolf Z, et al. 1992. P. Natl. Acad. Sci. USA 89:4210. (Block, IP) Hathcock KS, et al. 1994. J. Exp. Med. 180:631. (Block) Herold KC, et al. 1997. J. Immunol. 158:984. (Block, IHC) Ma XT, et al. 2006. Cancer Res. 66:1169. Andoniou CE, et al. 2005. Nature Immunology 6:1011. (FC) Lawson BR, et al. 2007. J. Immunol. 178:5366. Turnquist HR, et al. 2007. J. Immunol. 178:7018. Misra RS, et al. 2010. J. Exp Med. 207:1775. PubMed del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed Philipsen L, et al. 2013. Mol Cell Proteomics. 12:2551. PubMed\u003cbr\u003e\nProduct Citations: Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed Sohn HS, et al. 2022. Sci Adv. 8:eabo5284. PubMed Chen H, et al. 2023. Nat Commun. 14:941. PubMed Cheng K, et al. 2023. Small. 19:e2300125. PubMed Sang H, et al. 2023. Adv Clin Exp Med. 32:551. PubMed Ma X, et al. 2023. Nat Commun. 14:1606. PubMed Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed Fu S, et al. 2023. Nat Commun. 14:2248. PubMed Li T, et al. 2023. Nat Commun. 14:2498. PubMed Li Y, et al. 2023. Front Cell Infect Microbiol. 13:1117230. PubMed Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed Wang K, et al. 2023. Nat Commun. 14:2950. PubMed Wang X, et al. 2023. Stem Cell Rev Rep. . PubMed Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed Wang S, et al. 2022. Sci Adv. 8:eabn3883. PubMed Gargaro M, et al. 2022. Immunity. 55:1032. PubMed Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed Liu M, et al. 2022. Cells. 11: . PubMed Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed Han J, et al. 2023. Front Microbiol. 13:1067725. PubMed Rozanski C, et al. 2011. J Exp Med. 208:1435. PubMed Mulder R, et al. 2017. Front Immunol. 1.464583333. PubMed Li X, et al. 2022. Nat Commun. 13:2794. PubMed Wilhelm J, et al. 2021. J Control Release. 329:353. PubMed Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed Kashyap AS, et al. 2019. Cell Rep. 28:3367. PubMed Wei H, et al. 2021. Malar J. 20:89. PubMed Gruber T, et al. 2020. JCI Insight. 5:00. PubMed Kodumudi KN, et al. 2019. Front Immunol. 10:1939. PubMed Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed Nagaoka M, et al. 2014. J Immunol. 193:2812. PubMed Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed Rafiq S, et al. 2018. Nat Biotechnol. 36:847. PubMed Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed Mardomi A, et al. 2021. J Cell Physiol. 236:6328. PubMed Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed Sharma S, et al. 2015. J Immunol. 194:5529. PubMed Bhattacharjee P, et al. 2018. Sci Rep. 13:e0199785. PubMed Wu J, et al. 2021. Mol Med Rep. 23:. PubMed Wong R, et al. 2020. Immunity. 53(5):1078-1094.e7. PubMed Uchil PD et al. 2018. Cell host \u0026amp; microbe. 25(1):87-100 . PubMed Lin SY, et al. 2017. Autophagy. 14:778. PubMed Utley A, et al. 2020. Cell Rep. 31:107815. PubMed Tsukasaki M, et al. 2020. Cell Reports. 32(10):108124. PubMed Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed Zhang F, et al. 2017. Mol Immunol. 10.1016\/j.molimm.2017.06.019. PubMed Pardy RD, et al. 2021. Nat Commun. 12:4051. PubMed Coe D, et al. 2022. JCI Insight. 7:. PubMed Glaros V, et al. 2021. Immunity. 54:2005. PubMed Mulas F, et al. 2020. Cell Mol Immunol. . PubMed Xie Z, et al. 2018. J Am Heart Assoc. 7:e007442. PubMed Florêncio KGD, et al. 2022. Front Immunol. 13:941757. PubMed Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed Guo L, et al. 2021. Vaccines (Basel). 9:. PubMed Ganesan R, et al. 2020. FASEB J. 34:15888. PubMed Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed Wong E, et al. 2012. J Immunol. 189:5667. PubMed White C, et al. 2015. J Immunol. 194:697. PubMed Matundan H, et al. 2019. J Virol. 93. PubMed Matundan HH, et al. 2021. J Virol. 95:e0103621. PubMed Wu G, et al. 2022. Wellcome Open Res. 6:134. PubMed Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed Vogel A, et al. 2022. STAR Protoc. 3:101653. PubMed Sun L, et al. 2015. Sci Rep. 5: 14871. PubMed Marshall N, et al. 2012. Cancer Res. 72:581. PubMed Yang C, et al. 2019. Nanomedicine (Lond). 14:2423. PubMed Tomay F, et al. 2019. J Transl Med. 17:237. PubMed Ma W, et al. 2017. Cell Death \u0026amp; Disease. 10.1038\/cddis.2017.47. PubMed Zhang X, et al. 2022. JCI Insight. 7:. PubMed Fan Q, et al. 2021. Bioact Mater. 6:4014. PubMed Ye Y, et al. 2017. Sci Immunol. 2:17. PubMed Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed Xu Q, et al. 2021. Theranostics. 11:1937. PubMed Kelly SH, et al. 2021. ACS Biomater Sci Eng. 7:1876. PubMed Li J, et al. 2022. Nat Commun. 13:4032. PubMed Wang X, et al. 2021. EMBO J. 40:e105926. PubMed He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed Luck H, et al. 2019. Nat Commun. 10:3650. PubMed Li Z, et al. 2022. Nat Commun. 13:6321. PubMed Stephens WZ, et al. 2021. Cell Rep. 37:109916. PubMed Izumi G, et al. 2021. Nat Commun. 12:5029. PubMed Qi J, et al. 2021. Nat Commun. 12:4755. PubMed Li J, et al. 2020. Development. :. PubMed Miura N, et al. 2017. Mol Ther. 10.1016\/j.ymthe.2017.01.020. PubMed Feng S, et al. 2021. Exp Ther Med. 21:20. PubMed Simmons D, et al. 2012. J Immunol. 188:3116. PubMed Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed Walker MT, et al. 2021. Front. Allergy. 2:. PubMed Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed Tateishi R, et al. 2015. PLoS One. 10: e0141650. PubMed Kelly SH, et al. 2021. Adv Healthc Mater. 10:e2001614. PubMed Piñón-Zárate G, et al. 2022. Molecules. 27:. PubMed Vogel A, et al. 2022. Cell Rep. 38:110420. PubMed Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed Knox T, et al. 2019. Sci Rep. 9:6136. PubMed Kadir NA, et al. 2020. Pathogens. 9:00. PubMed Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed Zhang X, et al. 2021. Front Pharmacol. 12:706748. PubMed Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed Lightman SM, et al. 2020. Cell Reports. 1.086805556. PubMed Chen R, et al. 2021. Front Oncol. 11:743050. PubMed Wang Y, et al. 2020. Vaccines (Basel). 8:. PubMed Jeisy-Scott V, et al. 2012. J Virol. 86:10988. PubMed Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed Lin YC, et al. 2020. Mol Med Rep. 22:4909. PubMed\u003cbr\u003e\nRRID: AB_313128 (BioLegend Cat. No. 104707) AB_313129 (BioLegend Cat. No. 104708)\u003cbr\u003e\nStructure: Ig superfamily, 60 kD\u003cbr\u003e\nDistribution: Macrophages, activated B cells and T cells, dendritic cells\u003cbr\u003e\nFunction: T cell costimulation\u003cbr\u003e\nLigand\/Receptor: CD28 (stimulatory), CD152(CTLA4) (inhibitory)\u003cbr\u003e\nCell Type: B cells, Dendritic cells, Macrophages, T cells, Tregs\u003cbr\u003e\nBiology Area: Cell Biology, Costimulatory Molecules, Immunology, Neuroscience, Neuroscience Cell Markers\u003cbr\u003e\nMolecular Family: CD Molecules, Immune Checkpoint Receptors\u003cbr\u003e\nAntigen References: 1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Linsley PS, et al. 1991. J. Exp. Med. 174:561. 3. Salomon B, et al. 2001. Annu. Rev. Immunol. 19:225.\u003cbr\u003e\nGene ID: 12519\u003cbr\u003e\nUniProt: View information about CD80 on UniProt.org\u003cbr\u003e\nClone: 16-10A1\u003cbr\u003e\nRegulatory Status: RUO\u003cbr\u003e\nOther Names: B7-1, B7, Ly-53\u003cbr\u003e\nIsotype: Armenian Hamster IgG\u003cbr\u003e\nQ: What type of PE do you use in your conjugates?\u003cbr\u003e\nA: We use R-PE in our conjugates.\u003c\/p\u003e","brand":"Biolegend","offers":[{"title":"Default Title","offer_id":46860814942377,"sku":"104707","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/es\/products\/biolegend-104707","provider":"Iright","version":"1.0","type":"link"}